0001493152-23-041355.txt : 20231114
0001493152-23-041355.hdr.sgml : 20231114
20231114190222
ACCESSION NUMBER: 0001493152-23-041355
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231110
FILED AS OF DATE: 20231114
DATE AS OF CHANGE: 20231114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SAHAREK JOHN P.
CENTRAL INDEX KEY: 0001632091
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 231408555
MAIL ADDRESS:
STREET 1: 12264 EL CAMINO REAL
STREET 2: SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER NAME:
FORMER CONFORMED NAME: Saharek John
DATE OF NAME CHANGE: 20150128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARROW, INC.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
BUSINESS PHONE: 615.733.4731
MAIL ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
FORMER COMPANY:
FORMER CONFORMED NAME: HARROW HEALTH, INC.
DATE OF NAME CHANGE: 20181228
FORMER COMPANY:
FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20120301
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
4
1
ownership.xml
X0508
4
2023-11-10
0
0001360214
HARROW, INC.
HROW
0001632091
SAHAREK JOHN P.
C/O HARROW HEALTH, INC.
102 WOODMONT BLVD, SUITE 610
NASHVILLE
TN
37205
0
1
0
0
Chief Commercial Officer
0
Common Stock
2023-11-10
4
M
0
20000
A
242197
D
Common Stock
2023-11-10
4
F
0
9778
12.83
D
232419
D
Stock Option (Right to Buy)
4.16
2023-11-10
4
M
0
20000
0
D
2023-11-12
Common Stock
20000
0
D
Shares withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions.
The stock option was granted on November 12, 2013 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of November 12, 2023.
/s/ John P. Saharek
2023-11-14